您好,欢迎来到试剂信息网! [登录] [免费注册]
试剂信息网
位置:首页 > 产品库 > L-BUTHIONINE-(S,R)-SULFOXIMINE
立即咨询
咨询类型:
     
*姓名:
*电话:
*单位:
Email:
*留言内容:
请详细说明您的需求。
*验证码:
 
L-BUTHIONINE-(S,R)-SULFOXIMINE
本产品不向个人销售,仅用作科学研究,不用于任何人体实验及非科研性质的动物实验。
L-BUTHIONINE-(S,R)-SULFOXIMINE图片
CAS NO:83730-53-4
包装与价格:
包装价格(元)
10 mM * 1 mL in Water电议
50mg电议
100mg电议
200mg电议
500mg电议

产品名称
L-Buthionine sulfoximine
L-BSO
产品介绍
L-Buthionine-(S,R)-sulfoximine 是一种具有细胞渗透性的、有效的、快速起效的、不可逆的G-谷氨酸半胱氨酸合成酶 (γ-glutamylcysteine synthetase)抑制剂,可降低细胞内谷胱甘肽的水平,其对黑色素瘤、乳腺卵巢癌标本的IC50值分别为1.9 μM、8.6 μM 和29 μM。
生物活性

L-Buthionine-(S,R)-sulfoximine is a cell-permeable, potent, fast acting and irreversible inhibitor ofg-glutamylcysteine synthetaseand depletes cellular glutathione levels. TheIC50value of L-Buthionine-(S,R)-sulfoximine on melanoma, breast and ovarian tumor specimens are 1.9 μM, 8.6 μM, and 29 μM, respectively.

IC50& Target

γ-glutamylcysteine synthetase[1].

体外研究
(In Vitro)

L-Buthionine-(S,R)-sulfoximine (BSO: 50 μM) treatment for 48 hr results in a 95% decrease in ZAZ and M14 melanoma cell line GSH levels, and a 60% decrease in GST enzyme activity. GST-π protein and mRNA levels are significantly reduced in both cell lines[1]. L-Buthionine-(S,R)-sulfoximine (BSO) induces oxidative stress in a cell by irreversibly inhibiting g-glutamylcysteine synthetase, an essential enzyme for the synthesis of glutathione (GSH)[2].
L-Buthionine-(S,R)-sulfoximine (BSO) induces ferroptosis in cancer cells[3].

体内研究
(In Vivo)

BSO causes an elevated frequency of DNA deletions during mouse development. BSO treatment reduced GSH concentration in mouse fetuses by 55% and 70% at 2 mM and 20 mM BSO doses, respectively, compared to untreated mice. Co-treatment with 2 mM BSO and 20 mM NAC depleted GSH to a similar extent as 2 mM BSO, consistent with the function of BSO to inhibit the g-GCS enzyme indispensable for GSH synthesis. Like GSH, cysteine levels dropped following BSO treatment[2].

分子量

222.31

性状

Solid

Formula

C8H18N2O3S

CAS 号

83730-53-4

运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

-20°C, sealed storage, away from moisture

*In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)

溶解性数据
In Vitro: 

H2O : 18.33 mg/mL(82.45 mM;Need ultrasonic)

DMSO :< 1 mg/mL (ultrasonic)(insoluble or slightly soluble)

配制储备液
浓度溶剂体积质量1 mg5 mg10 mg
1 mM4.4982 mL22.4911 mL44.9822 mL
5 mM0.8996 mL4.4982 mL8.9964 mL
10 mM0.4498 mL2.2491 mL4.4982 mL
*

请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效
储备液的保存方式和期限:-80℃, 6 months; -20℃, 1 month (sealed storage, away from moisture)。-80℃ 储存时,请在 6 个月内使用,-20℃ 储存时,请在 1 个月内使用。

In Vivo:

请根据您的实验动物和给药方式选择适当的溶解方案。以下溶解方案都请先按照In Vitro方式配制澄清的储备液,再依次添加助溶剂:

——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议您现用现配,当天使用; 以下溶剂前显示的百
分比是指该溶剂在您配制终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶

  • 1.

    请依序添加每种溶剂: PBS

    Solubility: 100 mg/mL (449.82 mM); Clear solution; Need ultrasonic

*以上所有助溶剂都可在本网站选购。